scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF01233077 |
P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BF01233077.pdf |
http://link.springer.com/article/10.1007/BF01233077/fulltext.html | ||
http://link.springer.com/content/pdf/10.1007/BF01233077 | ||
P698 | PubMed publication ID | 7687385 |
P50 | author | James F. Gusella | Q1602688 |
P2093 | author name string | V. Ramesh | |
R. Geha | |||
N. Ramesh | |||
P2860 | cites work | Analytical Biochemistry | Q485215 |
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Assignment of the human Fas antigen gene (Fas) to 10q24.1 | Q28188700 | ||
Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter | Q28270961 | ||
Chromosomal location of the human tumor necrosis factor receptor genes | Q28303243 | ||
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
Assignment of two of the translation initiation factor-4E (EIF4EL1 and EIF4EL2) genes to human chromosomes 4 and 20. | Q34929317 | ||
The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias | Q35593137 | ||
Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50 | Q35612157 | ||
Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen | Q36230750 | ||
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis | Q41671465 | ||
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40 | Q41700086 | ||
A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family | Q44287536 | ||
A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. | Q53548006 | ||
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome | Q55670500 | ||
CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM | Q58478788 | ||
Mechanism of antigen-driven selection in germinal centres | Q59072211 | ||
Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM | Q59086599 | ||
Activation of human B lymphocytes through CD40 and interleukin 4 | Q69099068 | ||
Localization of the ornithine aminotransferase gene and related sequences on two human chromosomes | Q69902891 | ||
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome | Q72068543 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 295-298 | |
P577 | publication date | 1993-05-01 | |
P1433 | published in | Somatic Cell and Molecular Genetics | Q7559232 |
P1476 | title | Chromosomal localization of the gene for human B-cell antigen CD40 | |
P478 | volume | 19 |
Q40411048 | CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1). |
Q41134276 | CD40-CD40 ligand: a multifunctional receptor-ligand pair. |
Q34082784 | CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. |
Q40391934 | Molecular Pathology of X‐Linked Immunoglobulin Deficiency with Normal or Elevated IgM (HIGMX‐1) |
Q40391931 | The Role of CD40 and its Ligand in the Regulation of the Immune Response |
Q47998036 | The hyper-IgM (HIM) syndrome |
Q52618879 | The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis. |
Q40973851 | X-linked agammaglobulinemia and immunoglobulin deficiency with normal or elevated IgM: immunodeficiencies of B cell development and differentiation |
Q34099462 | X-linked hyper IgM syndrome |
Search more.